Emergex Vaccines Holding Ltd

BioTech/Drugs - Vale of White Horse, ENG, UK

Emergex Vaccines Holding Ltd Details

Emergex, a clinical-stage, privately-held biotechnology company headquartered in Abingdon, UK, with an operating subsidiary in Doylestown, Pennsylvania, USA, is pioneering the development of 100% synthetic T cell Adaptive Vaccines that harness the body's natural T cell immune response to destroy pathogen-infected cells for protection against some of the world's most pressing health threats, including viral infectious diseases, such as Dengue Fever, COVID-19, pandemic Influenza, as well as serious intra-cellular bacterial infections.Emergex has a growing pipeline of innovative CD8+ T cell Adaptive Vaccine and booster vaccine candidates that have the potential to deliver rapid, broad (mutation-agnostic) and long-lasting immunity to reduce serious illness associated with infectious disease. Emergex has a number of Phase I clinical trials underway, of which the most advanced programmes in development are Dengue Fever (which may also be disease-modifying for other members of the Flaviviridae virus family, such as Zika and Yellow Fever), as well as COVID-19. Other programmes in development include vaccine candidates for universal (pandemic) Influenza, Chikungunya, and a booster vaccine for Yellow Fever.Emergex's T cell Adaptive Vaccines candidates combine two proprietary technologies, [i] an empirically determined library of pathogen-derived protein fragments expressed on the surface of pathogen-infected cells (forming the MHC Class I expression "ligandome" library), and [ii] a passivated gold nanoparticle carrier system designed to deliver the synthetic peptides to the skin-resident immune system (in combination with nociception) via micro-needles to elicit a robust adaptive CD8 T cell response. With potential stability at ambient temperatures, the vaccine candidates as intended reduce the burden and logistics of vaccine administration.Find out more online at www.emergexvaccines.com.

Emergex Vaccines Holding Ltd logo, Emergex Vaccines Holding Ltd contact details
Employees: 20 - 49
HQ: N/A
Location: Vale of White Horse, ENG, UK
Revenue: 2.5 - 5 Million
N/A
Emergex Vaccines Holding Ltd Technologies
Email Providers

Outlook

Load Balancers

Apache

Fonts

Typekit

Tag Management

Google Tag Manager

Other

Microsoft Office 365

Online Video Platforms

YouTube

View All Technologies Used At Emergex Vaccines Holding Ltd

Contacting Emergex Vaccines Holding Ltd: Connect with Executives and Employees

Get in Touch with Emergex Vaccines Holding Ltd Executives and Employees

Connecting with Emergex Vaccines Holding Ltd's Executives and Workforce

Accessing Contact Information for Emergex Vaccines Holding Ltd Executives

Connecting with Emergex Vaccines Holding Ltd: Reach Out to Their Team

Discover How to Contact Emergex Vaccines Holding Ltd Executives and Staff

Looking to connect with Emergex Vaccines Holding Ltd executives or employees?

Seeking to Get in Touch with Emergex Vaccines Holding Ltd Executives or Staff?

Want to Reach Out to Emergex Vaccines Holding Ltd Executives or Team Members?

In Search of Contact Details for Emergex Vaccines Holding Ltd Professionals?

Connecting with Emergex Vaccines Holding Ltd: Contacting Executives and Staff

Browse companies
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z